A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma

CONCLUSION: The ARG-based signature may provide a promising direction for prognosis prediction and treatment optimization for DLBCL patients.PMID:38709202 | DOI:10.1080/14737159.2024.2351465
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Source Type: research